Moneycontrol PRO
HomeNewsBusinessStocksBuy, Sell, Hold: 7 stocks and 1 sector are on investors’ radar today

Buy, Sell, Hold: 7 stocks and 1 sector are on investors’ radar today

Tata Motors, HDFC and Cadila Health, among others, are being tracked by analysts on Thursday.

October 05, 2017 / 09:03 IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

M&M

Brokerage: CLSA | Rating: Upgrade to outperform | Target: Raised to Rs 1,610

CLSA observed that volume growth for the company is on an uptrend, while the tractor business is seeing strong demand. Moreover, the SUV business is a drag, but volumes are seeing a recovery on low base. In fact, it expects the upcoming MPV launch to boost FY19 growth. The stock, the brokerage said, looks attractive after underperforming the Nifty by 13 percent since June.

Tata Motors

Brokerage: Macquarie | Rating: Outperform | Target: Cut to Rs 525

The global research firm lowered FY18/FY19 EBITDA estimates by 4-5% on lower JLR sales volume. Going forward, the firm expects new models to drive growth despite a weak environment. It also highlighted how the management was confident of an improvement in JLR margin in the second half of this fiscal and FY19.

Housing Development Finance Corporation

Brokerage: Macquarie | Rating: Outperform | Target: Rs 1,890

Macquarie said that the management indicated temporary slowdown in the core mortgage business due to RERA Act. Moreover, loan growth of 15%+ in core mortgage book still possible. Listing Of life & AMC business, stable asset quality will be catalysts.

Jubilant Food

Brokerage: Macquarie | Rating: Outperform | Target: Rs 1,465

The global brokerage firm said that Dominos’ same-store-sales growth is seeing an uptick due to new campaign. It sees strong demand in some outlets on the back of models and establishment act. The company remains a top pick in the consumer discretionary space.

Motherson Sumi

Brokerage: HSBC | Rating: Buy | Target: Rs 365

HSBC said that an analysis suggests that arms account for 16-21 percent of the net profit. Further, it expects core business to continue to grow on more complexity in auto components.

Cadila Health

Brokerage: Credit Suisse | Rating: Outperform | Target: Rs 540

Credit Suisse said that the company benefits from an atenolol shortage as it is the only player to not face the shortage. The brokerage also observed that it increased capacity and share has ramped up to 47 percent now.

Kajaria

Brokerage: HSBC | Rating: Buy | Target: Raised to Rs 800

HSBC said that the industry is still facing headwinds but is slowly returning to normalcy. It expects the firm to benefit from market share gains with GST in place.

Financials

Brokerage: Credit Suisse

Credit Suisse said that SLR cut to benefit banks with high loan-to-deposit ratio. In case of LDR, for many private banks, this has reached 90 percent, while for PSUs, this has dropped to 50-740 percent. Going forward, it expects release of SLR will benefit HDFC Bank, Kotak, IndusInd Bank & Yes Bank. HDFC Bank, ICICI Bank & IndusInd Bank are its preferred picks.

first published: Oct 5, 2017 09:03 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347